Pneumonia News and Research

Latest Pneumonia News and Research

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

Thomson Reuters today released its annual study identifying the 100 top U.S. hospitals based on their overall organizational performance.

29 Mar 2010

New ways to halt the rise of antimicrobial-resistant infections

Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.

27 Mar 2010

Lay health workers can help reduce childhood mortality

Lay persons in many countries who are given special training to promote or carry out some health care services may reduce childhood mortality.

26 Mar 2010

Glaxosmithkline, Pfizer will supply 60M doses of reduced-price pneumococcal vaccines to developing countries over 10 years, GAVI says

The GAVI Alliance on Tuesday formally announced that drugmakers GlaxoSmithKline and Pfizer had signed off on a "10-year deal … to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations," Reuters reports.

25 Mar 2010

New study investigates effects of influenza among pregnant women

This spring, pregnant women in Bergen and Oslo will be invited to take part in the Norwegian Influenza Study (NorFlu). The aim is to find out how influenza in pregnancy affects maternal health and childhood development. NorFlu will also study any implications of vaccination during pregnancy.

25 Mar 2010

Pfizer to supply pneumococcal conjugate vaccines for infants and children

Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company’s 13-valent pneumococcal conjugate vaccine, for infants and young children in the world’s poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.

24 Mar 2010

Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine

Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia -- the world's biggest childhood killer, thanks to new agreements made with two major pharmaceutical firms, the GAVI Alliance announced today.

24 Mar 2010

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

Pharmaceutical giants have signed a historical 10-year deal on Tuesday pledging the supply of 60 million doses a year of pneumococcal vaccines at cut-prices to developing nations.

24 Mar 2010

HIV-infected patients face increase risk of CA-MRSA infections, says study

HIV-infected patients are at a markedly increased risk for community acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections according to a new study by researchers at John H. Stroger, Jr. Hospital of Cook County and Rush University Medical Center.

24 Mar 2010

Royal Philips Electronics introduces Lifeline with AutoAlert solution

Royal Philips Electronics today introduced Lifeline with AutoAlert, an enhanced medical alert service. This integrated solution offers an added layer of protection by combining the industry-leading Philips Lifeline medical alert service with automatic fall detection capabilities.

From Philips Healthcare 23 Mar 2010

First reported Australian swine flu case of 2010 – gearing up with protective measures

Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.

23 Mar 2010

Chest x-rays may help identify high-risk H1N1 patients

A new study published in the April issue of Radiology suggests that chest x-rays may play an important role in the diagnosis and treatment of H1N1 influenza by predicting which patients are likely to become sicker.

23 Mar 2010

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston.

23 Mar 2010

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

During the Fifth Decennial International Conference on Healthcare-Associated Infections, the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control and Epidemiology awarded their first Partnership in Prevention Award to the National Guard Health Affairs in Saudi Arabia.

20 Mar 2010

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Scientists at The Virginia Commonwealth University Medical Center found that an emphasis on compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing (a daily bath with the same antibacterial agent used by surgeons to "scrub in" before an operation), is successful in reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus.

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

Nature News examines GAVI Alliance's budget gap

Nature News examines GAVI Alliance's multi-billion-dollar budget shortfall ahead of a donors meeting in The Hague on March 25-26.

18 Mar 2010

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.

17 Mar 2010

Pneumonia News and Research

Latest Pneumonia News and Research

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

New ways to halt the rise of antimicrobial-resistant infections

Lay health workers can help reduce childhood mortality

Glaxosmithkline, Pfizer will supply 60M doses of reduced-price pneumococcal vaccines to developing countries over 10 years, GAVI says

New study investigates effects of influenza among pregnant women

Pfizer to supply pneumococcal conjugate vaccines for infants and children

Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

HIV-infected patients face increase risk of CA-MRSA infections, says study

Royal Philips Electronics introduces Lifeline with AutoAlert solution

First reported Australian swine flu case of 2010 – gearing up with protective measures

Chest x-rays may help identify high-risk H1N1 patients

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Nature News examines GAVI Alliance's budget gap

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in